Dermatology News and Research

Latest Dermatology News and Research

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are intended to increase surgeons' efficiency, while improving case predictability for ophthalmic surgeries.

21 Sep 2011

NIH announces recipients of 2011 Transformative Research Award Projects

The National Institutes of Health has announced the recipients of the 2011 Transformative Research Award Projects. This innovative research program was established in 2009 to support exceptionally innovative, high risk, original and/or unconventional research projects, and is supported by the NIH Common Fund.

21 Sep 2011

NYU Langone creates new Joan H. Tisch Center for Women's Health in New York City

NYU Langone Medical Center announced the establishment of its new Joan H. Tisch Center for Women's Health on the Upper East Side of Manhattan in New York City.

20 Sep 2011

MUHC orders GlobalMed TotalExam 2 Examination Cameras for Québec telemedicine program

McGill University Hospital Centre in Montréal, Canada, has ordered 95 TotalExam2 Examination Cameras from Scottsdale, Arizona-based GlobalMed for its telemedicine program in the province of Québec. GlobalMed, the industry leader in telemedicine design, manufacturing and marketing, developed TotalExam to deliver crystal clear digital close-ups of the skin, eyes and throat.

19 Sep 2011

KYTHERA closes $37.4M Series D financing

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of products in aesthetic medicine, today announced the closing of a $37.4M Series D financing.

19 Sep 2011

Meda acquires exclusive licensing rights to Nalox from Moberg Derma

Meda has acquired exclusive licensing rights to Nalox (treatment of fungal nail infections/nail psoriasis) from Moberg Derma AB.

19 Sep 2011

InNexus Biotechnology announces incentive stock options

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announces that it has, effective August 26, 2011, granted incentive stock options to purchase an aggregate of 1,068,683 common shares without par value in the capital of the Company to certain persons who are either a director, officer, employee or consultant of the Company.

17 Sep 2011

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.

14 Sep 2011

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Hawthorn Pharmaceuticals, Inc. announced today an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.

13 Sep 2011

Work intensity of physicians across several specialties is fairly equal: Study

Contrary to longstanding assumptions, new findings suggest the work intensity of physicians across several specialties is fairly equal. The study, funded by the American Academy of Neurology along with several other medical associations and published online ahead of print in the journal Medical Care, provides the groundwork for the development of a more reliable, scientific measurement of physician work intensity that may guide future national policy in patient safety, practice management and payment.

12 Sep 2011

UC research: Physicians report similar degrees of work intensity

Although society's perception might be that surgeons endure greater mental challenges and stress in their work duties than a primary care doctor, new research from experts at the University of Cincinnati (UC) shows that this isn't necessarily the case.

9 Sep 2011

Theraplex unveils new line of aesthetics skin care products

The Theraplex Company, makers of the theraplex line of medical moisturizers, unveiled a new line of aesthetics skin care products called theraesthetics at the recent Cosmetic Bootcamp in Aspen, Colorado.

8 Sep 2011

New guidelines for treatment of melanoma

Based on an extensive review of scientific literature and the recommendations of recognized melanoma experts, the American Academy of Dermatology (Academy) has released updated evidence-based guidelines for the treatment of melanoma, the deadliest form of skin cancer.

8 Sep 2011

New head louse treatment shows promise

The common head louse has been seen to be resistant to time-tested treatments. However a new Food and Drug Administration-approved hair rinse, Natroba, could put an end to that.

6 Sep 2011

Further acne treatment studies necessary: Experts

Researchers writing in the journal The Lancet suggest further research that is urgently needed for effective non-antibiotic treatments for acne, because of concerns regarding long-term antibiotic use and its contribution to bacterial resistance. Pharmacies are well stocked with a wide range of acne medications. However, evidence regarding their efficacy and which treatments work best for whom are limited, the authors added.

31 Aug 2011

Sunscreen pills from coral

Researchers have found that coral does not suffer from sunburn despite living in shallow water in tropical areas, because it is able to produce its own “natural sunscreen”. By studying the compounds which protect it from UV rays, researchers hope to develop a tablet which can protect human skin and eyes without the need for dark glasses or sun cream. Scientists from King's College London said the first sunscreen pill could be available within five years.

31 Aug 2011

IRIDEX introduces new XP Module for IQ 532 ENT laser system

IRIDEX Corporation announced the introduction of its new XP Module - a high power factory installed option for the IRIDEX IQ 532 green laser system.

31 Aug 2011

Valeant to acquire Afexa for C$76 million in cash

Valeant Pharmaceuticals International, Inc., announced today that it has agreed to acquire Afexa Life Sciences Inc. for approximately C$76 million.

31 Aug 2011

Men reluctant to use sunscreen- survey

A new survey claims that less than half of men use sunscreen of at least factor 15 to protect their skin from damage.

30 Aug 2011

Countdown begins for GP11 – The Conference for General Practice

With only six weeks to go until the Royal Australian College of General Practitioner’s (RACGP) annual conference - GP11, final preparations are well underway for what will be an outstanding program of presentations, workshops and social networking opportunities for GPs and allied healthcare professionals.

25 Aug 2011